Andrew A Guirguis
Andrew Guirguis is a Clinical Haematologist at Austin Health and a Clinical Lab Head at the Olivia Newton-John Cancer Research Institute in Melbourne, Victoria since 2024. His clinical and research interests focus on understanding and targeting drivers of pre-leukaemic myeloid neoplasms, including the myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and myeloproliferative neoplasms (MPN). A University of Melbourne graduate, Andrew holds dual fellowships with the Royal Australasian College of Physicians (RACP) and the Royal College of Pathologists of Australasia (RCPA). He completed haematology training at the Alfred Hospital and a PhD at the Australian Centre for Blood Diseases, earning the HSANZ Baikie Medal. His postdoctoral research includes fellowships under Professor Ben Ebert at the Dana-Farber Cancer Institute and Professor Mark Dawson at the Peter MacCallum Cancer Centre. Andrew serves on the Acute Leukaemia and Laboratory Science Working Parties within the Australasian Leukaemia and Lymphoma Group (ALLG).
Abstracts this author is presenting: